DeBernardo R

No ORCID on file · 3 papers in corpus · active 2013-2023

Study types

  • other 1

Condition tags

  • endometriosis 1
other 2023
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283
Gynecologic oncology ·doi:10.1016/j.ygyno.2023.06.021

OBJECTIVE: Gynecologic cancers are traditionally managed according to their presumed site of origin, without regard to the underlying histologic subtype. Clear cell histology is associated with chemotherapy refractoriness and poor survival.…

2018
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response.
NPJ precision oncology ·doi:10.1038/s41698-018-0060-3

There has been little progress in the use of patient-derived xenografts (PDX) to guide individual therapeutic strategies. In part, this can be attributed to the operational challenges of effecting successful engraftment and testing multiple…

2013
Cyberknife radiotherapy and anastrozole for the treatment of advanced progressive low-grade papillary serous ovarian carcinoma: A case report.
Gynecologic oncology case reports ·doi:10.1016/j.gynor.2013.09.002

•Low-grade papillary serous ovarian carcinoma has unique epidemiologic and disease-specific characteristics•Cyberknife radiotherapy is a unique treatment that may successfully be used to treat unresectable disease•Anastrozole is an effectiv…